5 Results for "

FLT3/ITD-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "FLT3/ITD-IN-1" in MCE Product Catalog:

Cat. No.: HY-144709
Target:  

FLT3

Research Areas:  

Cancer

FLT3/ITD-IN-1 (Compound 1) is a potent FLT3 internal tandem duplications (FLT3-ITD) inhibitor with IC50 values of 38.2 nM and 144.1 nM against FLT3 and FLT3-ITD, respectively. FLT3/ITD-IN-1 displays excellent antiproliferative activities against acute myeloid leukemia cell lines [1].
loading...
    loading...
Cat. No.: HY-162037
CAS No.: 2241659-94-7
Target:  

CDK FLT3

Research Areas:  

Cancer

CDDD11-8 is an orally active, potent and selective inhibitor of CDK9 and FLT3-ITD, with Ki values of 8 and 13 nM, respectively. CDDD11-8 reduces the proliferation of leukemia cell lines and was particularly effective against those harboring FLT3-ITD mutation .
loading...
    loading...
Cat. No.: HY-145902
CAS No.: 2761259-05-4
Target:  

PDGFR FLT3

Research Areas:  

Cancer

PDGFRα/FLT3-ITD-IN-1 (Compound 12d) is a potent inhibitor of PDGFRα/FLT3 with IC50s of more than 0.036 and 0.003 μM, respectively. PDGFRα/FLT3-ITD-IN-1 has the potential for the research of acute myeloid leukemia or chronic eosinophilic leukemia [1].
loading...
    loading...
Cat. No.: HY-145691
CAS No.: 381173-58-6
Target:  

FLT3

Research Areas:  

Cancer

HP1142 is a potent and selective inhibitor of FLT3 receptor tyrosine kinase (FLT3/ITD mutation). HP1142 is a benzoimidazole scaffold-based compound. HP1142 has the potential for the research of FLT3/ITD leukemia .
loading...
    loading...
Cat. No.: HY-145690
CAS No.: 2245074-20-6
Target:  

FLT3

Research Areas:  

Cancer

HP1328 is a potent inhibitor of FLT3 receptor tyrosine kinase (FLT3/ITD mutation). HP1328 is a benzoimidazole scaffold-based compound. HP1328 significantly reduces the leukemia burden and prolongs the survival of mice with FLT3/ITD leukemia .
loading...
    loading...